Michael E. Smith
Scott & White Hospital
Brain activity and meditationInternal medicineDevelopmental psychologyStimulus (physiology)PsychologyNeuroscienceCognitionNeurocognitiveCognitive psychologyVigilance (psychology)Working memoryMemoriaEvoked potentialTemporal lobeComputer scienceSpatial memoryElectroencephalographyAudiologyEvent-related potentialMedicineRecognition memory
Publications 65
Abstract Background Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in preventing infection with ...
5 CitationsSource
ABSTRACT BACKGROUND: Information is limited on messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) COVID-19 vaccine effectiveness (VE) in preventing SARS-CoV-2 infection or attenuating disease when administered in real-world conditions. METHODS: Prospective cohorts of 3,975 healthcare personnel, first responders, and other essential and frontline workers completed weekly SARS-CoV-2 testing during December 14 2020--April 10 2021. Self-collected mid-turbinate nasal swabs were t...
1 CitationsSource
#1Matthew Mo (UOW: University of Wollongong)
#2Mike Roache (UOW: University of Wollongong)
Last. Justin A. Welbergen (USYD: University of Sydney)H-Index: 22
view all 40 authors...
Mass mortalities in flying-foxes occur in summers that reach extremely hot temperatures. In this study, we examine the spatiotemporal distributions of mortality from pup abandonments and extreme heat events in Australian flying-fox camps during the 2019–20 summer. We recorded data on flying-fox mortality in known affected camps and applied a standard method to estimate the number of deaths. Pup mortalities from abandonments were recorded in 10 camps in New South Wales. A minimum estimate of 2612...
Messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) COVID-19 vaccines have been shown to be effective in preventing symptomatic COVID-19 in randomized placebo-controlled Phase III trials (1,2); however, the benefits of these vaccines for preventing asymptomatic and symptomatic SARS-CoV-2 (the virus that causes COVID-19) infection, particularly when administered in real-world conditions, is less well understood. Using prospective cohorts of health care personnel, first respond...
41 CitationsSource
OBJECTIVE To assess treatment effects on Expanded Disability Status Scale (EDSS) score worsening and modified Rankin Scale (mRS) scores in the N-MOmentum trial of inebilizumab, a humanized anti-CD19 monoclonal antibody, in participants with neuromyelitis optica spectrum disorder (NMOSD). METHODS Adults (N = 230) with aquaporin-4 immunoglobulin G-seropositive NMOSD or -seronegative neuromyelitis optica and an EDSS score ≤8 were randomized (3:1) to receive inebilizumab 300 mg or placebo on days 1 ...
1 CitationsSource
#1Jessie R. Chung (CDC: Centers for Disease Control and Prevention)H-Index: 17
#2Sara S Kim (CDC: Centers for Disease Control and Prevention)H-Index: 9
Last. Brendan Flannery (CDC: Centers for Disease Control and Prevention)H-Index: 52
view all 14 authors...
Abstract We compared symptoms and characteristics of 4961 ambulatory patients with and without laboratory-confirmed SARS-CoV-2 infection. Findings indicate that clinical symptoms alone would be insufficient to distinguish between COVID-19 and other respiratory infections (e.g., influenza) and/or to evaluate the effects of preventive interventions (e.g., vaccinations).
#1Jessie R. Chung (CDC: Centers for Disease Control and Prevention)H-Index: 17
#2Brendan Flannery (CDC: Centers for Disease Control and Prevention)H-Index: 52
Last. Manish M. Patel (CDC: Centers for Disease Control and Prevention)H-Index: 70
view all 14 authors...
Importance The burden of influenza among young children is high, and influenza vaccination is the primary strategy to prevent the virus and its complications. Less is known about differences in clinical protection following 1 vs 2 doses of initial influenza vaccination. Objectives To describe patterns of influenza vaccination among young children who receive outpatient care for acute respiratory tract illness in the US and compare vaccine effectiveness (VE) against medically attended laboratory-...
4 CitationsSource
#1Jessie R. Chung (CDC: Centers for Disease Control and Prevention)H-Index: 17
#2Brendan Flannery (CDC: Centers for Disease Control and Prevention)H-Index: 52
Last. Manish Patel (CDC: Centers for Disease Control and Prevention)H-Index: 1
view all 14 authors...
#2Mahesh JayaramH-Index: 11
Last. Michael E. SmithH-Index: 39
view all 3 authors...
Background Risperidone is the first new-generation antipsychotic drug made available in the market in its generic form. Objectives To determine the clinical effects, safety and cost-effectiveness of risperidone compared with placebo for treating schizophrenia. Search methods On 19th October 2015, we searched the Cochrane Schizophrenia Group Trials Register, which is based on regular searches of CINAHL, BIOSIS, AMED, EMBASE, PubMed, MEDLINE, PsycINFO, and registries of clinical trials. We checked...
40 CitationsSource
#1Elizabeth Bromley (WLAC: West Los Angeles College)H-Index: 15
#2Lisa Mikesell (WLAC: West Los Angeles College)H-Index: 12
Last. John S. Brekke (SC: University of Southern California)H-Index: 42
view all 5 authors...
Background. The ecological validity of neurocognitive and functional measures in severe mental illness is poorly understood because of a lack of validated research methods to study community life-as-lived. We describe the development of a video ethnography method that measures naturalistic behaviors with codes called community performance indicators (CPIs). The method could provide a strategy to test the ecological validity of neurocognitive and functional assessments. Methods. We gathered up to...
17 CitationsSource